Acumen Pharmaceuticals (ABOS) Total Liabilities (2020 - 2026)
Acumen Pharmaceuticals (ABOS) posted Total Liabilities of $46.2 million for Q1 2026, down 11.93% sequentially from $52.4 million in Q4 2025, and down 5.73% YoY from $49.0 million in Q1 2025.
Acumen Pharmaceuticals (ABOS) Total Liabilities (2020 - 2026) Analysis & Trends
Acumen Pharmaceuticals has reported Total Liabilities for 7 years, with the latest figure at $46.2 million in Q1 2026.
- Quarterly Total Liabilities fell 5.73% year-over-year to $46.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.2 million (down 5.73% YoY) and the FY2025 annual result came in at $52.4 million, down 8.35% from the prior year.
- Total Liabilities slipped to $46.2 million in Q1 2026 per ABOS's latest filing, from $52.4 million in the prior quarter.
- Over five years, Total Liabilities peaked at $57.2 million in Q4 2024 and troughed at $4.0 million in Q1 2022.
- A 5-year average of $31.3 million and a median of $43.2 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities surged 716.22% in 2024, then declined 8.35% in 2025.
- Over 5 years, Total Liabilities stood at $7.8 million in 2022, then soared by 452.38% to $43.2 million in 2023, then soared by 32.5% to $57.2 million in 2024, then fell by 8.35% to $52.4 million in 2025, then fell by 11.93% to $46.2 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $46.2 million, $52.4 million, and $49.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Acumen Pharmaceuticals | 226.87 Mn | 226.87 Mn | - | 58.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.74 Mn |
| Mar 31, 2026 | 46.15 Mn |
| Dec 31, 2025 | 52.40 Mn |
| Sep 30, 2025 | 49.05 Mn |
| Jun 30, 2025 | 54.82 Mn |
| Mar 31, 2025 | 48.96 Mn |
| Dec 31, 2024 | 57.18 Mn |
| Sep 30, 2024 | 49.77 Mn |
| Jun 30, 2024 | 44.97 Mn |
| Mar 31, 2024 | 38.93 Mn |
| Dec 31, 2023 | 43.15 Mn |
| Sep 30, 2023 | 6.10 Mn |
| Jun 30, 2023 | 8.53 Mn |
| Mar 31, 2023 | 8.78 Mn |
| Dec 31, 2022 | 7.81 Mn |
| Sep 30, 2022 | 6.61 Mn |
| Jun 30, 2022 | 5.16 Mn |
| Mar 31, 2022 | 4.00 Mn |
| Dec 31, 2021 | 5.15 Mn |
| Sep 30, 2021 | 1.49 Mn |